Edwards Lifesciences Income Statement (2009-2026) | EW

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	1,376.00M	1,310.20M	1,329.70M	1,341.20M	1,373.90M	1,319.00M	429.90M	1,221.30M	1,278.90M	1,243.40M	1,266.40M	1,329.90M	1,369.40M	1,354.40M	1,385.80M	1,412.70M	1,532.20M	1,553.10M	1,569.60M	1,648.60M
Cost of Revenue (Quarter)	334.30M	311.70M	309.50M	299.30M	269.40M	253.80M	-98.80M	329.50M	256.90M	250.60M	251.00M	286.90M	275.50M	262.90M	292.20M	301.60M	344.40M	345.20M	343.00M	362.60M
Gross Profit (Quarter)	1,041.70M	998.50M	1,020.20M	1,041.90M	1,104.50M	1,065.20M	528.70M	992.30M	1,031.10M	992.80M	1,015.40M	1,043.00M	1,093.90M	1,091.50M	1,093.60M	1,111.10M	1,187.80M	1,207.90M	1,226.60M	1,286.00M
Operating items
Research & Development (Quarter)	225.30M	238.00M	232.80M	228.60M	250.80M	233.60M	130.60M	261.20M	243.70M	242.80M	242.10M	256.70M	271.80M	253.40M	271.10M	254.60M	276.20M	280.70M	267.70M	263.30M
Selling, General & Administrative (Quarter)	374.50M	364.40M	424.00M	370.30M	409.00M	377.30M	201.00M	436.30M	410.40M	381.90M	416.60M	428.40M	447.50M	421.40M	491.90M	465.70M	502.00M	514.60M	602.90M	522.20M
Restructuring Costs (Quarter)	2.40M	4.70M	7.10M	7.10M	6.10M	-2.40M	49.90M	37.00M	147.90M	2.20M	9.90M			10.80M	7.50M	4.20M	4.20M	0.10M	-103.70M	37.10M
Other Operating Expenses (Quarter)														-22.40M	22.70M	19.10M	21.30M	12.50M	14.30M	14.20M
Operating Expenses (Quarter)	602.20M	607.10M	663.90M	606.00M	665.90M	608.50M	381.50M	734.50M	802.00M	626.90M	668.60M	685.10M	719.30M	685.60M	770.50M	724.50M	782.40M	795.40M	766.90M	822.60M
Operating Income (Quarter)	542.10M	390.30M	374.40M	438.80M	459.50M	402.40M	197.70M	388.40M	263.50M	365.90M	346.80M	349.00M	366.50M	350.60M	312.60M	394.80M	411.20M	307.10M	151.10M	477.60M
EBIT (Quarter)	542.10M	390.30M	374.40M	438.80M	459.50M	402.40M	197.70M	388.40M	263.50M	365.90M	346.80M	349.00M	366.50M	350.60M	312.60M	394.80M	411.20M	307.10M	151.10M	477.60M
Non-operating items
Interest & Investment Income (Quarter)												16.50M	15.50M	24.30M	64.00M	36.50M	37.40M	38.60M	56.30M	33.50M
Other Non Operating Income (Quarter)	4.40M	1.40M	1.40M	-3.30M	4.30M	-2.00M	5.80M	1.60M	2.50M	6.60M	3.60M	5.70M	2.00M	27.90M	33.30M	2.60M	-1.30M	2.70M	3.20M	71.50M
Non Operating Income (Quarter)	4.40M	1.40M	1.40M	-3.30M	4.30M	-2.00M	5.80M	1.60M	2.50M	6.60M	3.60M	22.20M	2.00M	27.90M	33.30M	2.60M	-1.30M	41.30M	-60.70M	71.50M
Net income details
EBT (Quarter)	545.50M	390.90M	376.30M	436.10M	464.70M	407.30M	211.40M	398.60M	275.10M	387.60M	367.20M	371.20M	384.00M	402.80M	390.10M	433.90M	400.20M	348.40M	90.40M	459.00M
Tax Provisions (Quarter)	56.00M	50.80M	41.00M	62.50M	58.30M	63.80M	10.90M	58.10M	20.90M	52.70M	34.10M	46.30M	20.00M	40.70M	45.10M	70.30M	64.30M	56.10M	26.20M	78.30M
Profit After Tax (Quarter)	489.50M	340.10M	335.30M	373.60M	406.40M	343.50M	200.50M	340.50M	307.10M	383.70M	333.10M	351.00M	365.00M	3,070.80M	384.30M	363.60M	331.50M	293.10M	87.10M	380.70M
Equity Income (Quarter)
Income from Non-Controlling Interests (Quarter)									-1.60M	-1.20M	-0.20M	-0.90M	-1.30M	-1.40M	-1.30M	-1.60M	-1.70M	-0.80M	0.00
Income from Continuing Operations (Quarter)	489.50M	340.10M	335.30M	373.60M	406.40M	343.50M	200.50M	340.50M	254.20M	334.90M	333.10M	324.90M	364.00M	362.10M	345.00M	363.60M	335.90M	292.30M	64.20M	380.70M
Consolidated Net Income (Quarter)	489.50M	340.10M	335.30M	373.60M	406.40M	343.50M	200.50M	39.90M	54.10M	48.80M	36.60M	26.10M	1.00M	2,707.30M	39.30M	-7.20M	-4.40M	-2.00M	27.00M
Income towards Parent Company (Quarter)	489.50M	340.10M	335.30M	373.60M	406.40M	343.50M	200.50M	39.90M	54.10M	48.80M	36.60M	26.10M	1.00M	2,707.30M	39.30M	-7.20M	-4.40M	-2.00M	27.00M
Net Income towards Common Stockholders (Quarter)	489.50M	340.10M	335.30M	373.60M	406.40M	343.50M	398.40M	340.50M	54.10M	48.80M	36.60M	26.10M	1.00M	2,707.30M	39.30M	-7.20M	-4.40M	-2.00M	27.00M
Additional items
EPS (Basic) (Quarter)	0.79	0.55	0.54	0.60	0.65	0.55	0.65	0.49	0.51	0.55	0.55	0.54	0.61	5.14	0.58	0.61	0.57	0.50	0.11	0.66
EPS (Weighted Average and Diluted) (Quarter)	0.78	0.54	0.53	0.59	0.65	0.55	0.65	0.49	0.50	0.55	0.61	0.58	0.61	5.13	0.65	0.61	0.56	0.50	0.11	0.66
Shares Outstanding (Weighted Average) (Quarter)	622.30M	623.60M	623.30M	622.10M	621.50M	621.00M	619.00M	607.50M	606.90M	607.00M	606.70M	601.60M	601.80M	597.20M	597.70M	586.90M	587.00M	584.70M	584.80M	579.20M
Shares Outstanding (Diluted Average) (Quarter)	630.60M	631.70M	631.20M	629.40M	626.70M	626.90M	624.20M	610.90M	610.30M	609.50M	609.40M	604.10M	604.30M	598.10M	599.30M	587.80M	587.90M	585.70M	585.80M	580.70M
EBITDA (Quarter)	542.10M	390.30M	374.40M	438.80M	459.50M	402.40M	197.70M	388.40M	263.50M	365.90M	346.80M	349.00M	366.50M	350.60M	312.60M	394.80M	411.20M	307.10M	151.10M	477.60M
Interest Expenses (Quarter)
Tax Rate (Quarter)	10.27%	13.00%	10.90%	14.33%	12.55%	15.66%	5.16%	14.58%	7.60%	13.60%	9.29%	12.47%	5.21%	10.10%	11.56%	16.20%	16.07%	16.10%	28.98%	17.06%

Research Tools

Edwards Lifesciences Income Statement (2009-2026) | EW

Create an account

Sign In

Reset Password